 |
Nearly half of treated patients had five years’ progression-free survival after transplant Related items from OnMedica New multiple sclerosis drug hailed as a 'landmark' A clinical review of multiple sclerosis High cost of unscheduled care for MS patients MS progression worse in patients who smoke GPs have little confidence in primary care neurology services |
Tuesday, 21 February 2017
Stem cell transplant shows promise for MS outcomes
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment